MX2017005108A - Formulaciones que contienen aceite de semilla de granada, aceite del fruto de rosa canina y oleorresina o extracto de inula viscosa. - Google Patents

Formulaciones que contienen aceite de semilla de granada, aceite del fruto de rosa canina y oleorresina o extracto de inula viscosa.

Info

Publication number
MX2017005108A
MX2017005108A MX2017005108A MX2017005108A MX2017005108A MX 2017005108 A MX2017005108 A MX 2017005108A MX 2017005108 A MX2017005108 A MX 2017005108A MX 2017005108 A MX2017005108 A MX 2017005108A MX 2017005108 A MX2017005108 A MX 2017005108A
Authority
MX
Mexico
Prior art keywords
oil
extract
formulations containing
pomegranate seed
seed oil
Prior art date
Application number
MX2017005108A
Other languages
English (en)
Inventor
SOFER Tzeira
MEYER Tamara
Original Assignee
Pomega Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pomega Inc filed Critical Pomega Inc
Publication of MX2017005108A publication Critical patent/MX2017005108A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/738—Rosa (rose)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/76—Salicaceae (Willow family), e.g. poplar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8998—Hordeum (barley)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Insects & Arthropods (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención se refiere, en términos generales, a formulaciones curativas que contienen aceite de semilla de granada, aceite de fruto de rosa canina, y oleorresina o extracto de inula viscosa. En algunos casos, las formulaciones pueden también contener aceite o extracto de citrus medica vulgaris etrog y otros ingredientes. Las formulaciones curativas son todas naturales, no incluyen conservadores artificiales y son seguras y eficaces para el tratamiento de ciertos trastornos y condiciones cutáneas.
MX2017005108A 2014-10-31 2015-11-02 Formulaciones que contienen aceite de semilla de granada, aceite del fruto de rosa canina y oleorresina o extracto de inula viscosa. MX2017005108A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462073905P 2014-10-31 2014-10-31
PCT/US2015/058682 WO2016070194A1 (en) 2014-10-31 2015-11-02 Formulations containing pomegranate seed oil, rosa canina fruit oil and inula viscosa oleoresin or extract

Publications (1)

Publication Number Publication Date
MX2017005108A true MX2017005108A (es) 2018-03-06

Family

ID=55858459

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2017005108A MX2017005108A (es) 2014-10-31 2015-11-02 Formulaciones que contienen aceite de semilla de granada, aceite del fruto de rosa canina y oleorresina o extracto de inula viscosa.
MX2023002137A MX2023002137A (es) 2014-10-31 2017-04-20 Formulaciones que contienen aceite de semilla de granada, aceite del fruto de rosa canina y oleorresina o extracto de inula viscosa.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2023002137A MX2023002137A (es) 2014-10-31 2017-04-20 Formulaciones que contienen aceite de semilla de granada, aceite del fruto de rosa canina y oleorresina o extracto de inula viscosa.

Country Status (7)

Country Link
US (1) US11058735B2 (es)
EP (3) EP4248981A3 (es)
JP (2) JP7313118B2 (es)
CA (1) CA2966325A1 (es)
IL (2) IL276734B2 (es)
MX (2) MX2017005108A (es)
WO (1) WO2016070194A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11576853B2 (en) 2015-04-29 2023-02-14 CSI: Create.Solve. Innovate. LLC Antioxidant compositions and methods of protecting skin, hair and nails against high energy blue-violet light
GB2561818B (en) * 2017-03-30 2020-01-15 Phyto Sophos Ltd Plant extract compositions
GB2576269B (en) * 2017-03-30 2020-07-15 Phyto Sophos Ltd Plant extract compositions
GB2576642B (en) * 2017-03-30 2020-07-22 Phyto Sophos Ltd Plant extract compositions
GB2576641B (en) * 2017-03-30 2020-07-15 Phyto Sophos Ltd Plant extract compositions
GB2576646B (en) * 2017-03-30 2020-07-15 Phyto Sophos Ltd Colloidal silver combined with plant extracts for use in treating wounds and other skin conditions
IT201700064400A1 (it) * 2017-06-12 2018-12-12 Elena Catalina Bistreanu Composizione a base di argento colloidale e suo uso topico per il trattamento della psoriasi
TR201722083A2 (tr) * 2017-12-27 2019-07-22 Montero Gida Sanayi Ve Ticaret Anonim Sirketi Göğüs ucu ve areolaya i̇li̇şki̇n rahatsizliklarin tedavi̇si̇ne yöneli̇k bi̇leşi̇m
US20200171083A1 (en) * 2018-11-29 2020-06-04 American Silver, Llc Compositions of silver and cannabinoids
AU2020373050A1 (en) * 2019-11-01 2022-05-26 Swm Luxembourg Fibrous product for medicinal, cosmetic or dermatologic use
US11213551B1 (en) * 2021-04-05 2022-01-04 Korb Research, Llc. Ocular treatment compositions and methods of use thereof
WO2023166796A1 (ja) * 2022-03-03 2023-09-07 学校法人 明治薬科大学 精油組成物

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941908A (en) 1973-03-08 1976-03-02 Western Electric Company, Inc. Strand material covered with clear flame retardant composition and methods of making
IL80329A (en) * 1986-10-15 1992-03-29 Moraz Medicinal Herbs Ltd Anti-viral preparations comprising plant extracts
US5411733A (en) 1992-04-27 1995-05-02 Hozumi; Toyoharu Antiviral agent containing crude drug
EP0744896B1 (en) 1994-02-17 1998-08-12 MERCK PATENT GmbH Antiviral or antifungal composition and method
DE19630092A1 (de) 1996-07-26 1998-01-29 Sachsenring Automobiltechnik G Verfahren zum Erfassen und/oder zur Zahlung eines Entgelts für Abgas-Schadstoffe und Kraftfahrzeug mit einem nach diesem Verfahren arbeitenden Abgas-Schadstoff-Set
BR9711019A (pt) * 1996-08-02 1999-08-17 Plum Kemi Prod EmulsÆo de Äleo-em- gua para uso em pela humana para limpeza preserva-Æo ou aperfei-oamento da condi-Æo da pele
US5698206A (en) * 1996-12-05 1997-12-16 Swedish Herbal Systems, Inc. Topical composition for the treatment of spider veins
US6113940A (en) * 1997-03-03 2000-09-05 Brooke; Lawrence L. Cannabinoid patch and method for cannabis transdermal delivery
AU7472398A (en) * 1997-05-09 1998-11-27 Medlogic Global Corporation Compositions for cosmetic applications
JP2002173405A (ja) 2000-12-04 2002-06-21 Hidehiro Tagusari コロイド銀による殺菌方法及びこれを用いた殺菌処理材
KR100858768B1 (ko) * 2001-06-21 2008-09-16 교와 핫꼬 고교 가부시끼가이샤 식물체 분말 함유 식물 추출물의 제조 방법
US7357950B2 (en) * 2003-03-21 2008-04-15 Elizabeth Anne Mazzio Topical treatment for dyshidrosis (pompholyx) and dry skin disorders
US20050158258A1 (en) * 2004-01-21 2005-07-21 Mary Kay Inc. Methods and compositions for the treatment of skin changes associated with aging and environmental damage
WO2005097187A2 (en) * 2004-04-01 2005-10-20 The General Hospital Corporation Methods of preventing uvb-induced skin damage
WO2005117925A1 (en) 2004-06-01 2005-12-15 Avisco Ltd. Novel inula viscosa extracts and their use for treatment of arthritis
JP2006104098A (ja) 2004-10-04 2006-04-20 Ichimaru Pharcos Co Ltd ヒアルロニダーゼ活性阻害剤
WO2007004229A2 (en) * 2005-07-06 2007-01-11 Rimonest Ltd. Methods of using pomegranate fractions for skin repair
US20080166313A1 (en) * 2005-11-01 2008-07-10 Juice Beauty Compositions for juice-based skin cleansers
DE202006019183U1 (de) * 2006-12-15 2007-04-19 Franz, Tanja Sanddorn-Hautpflegeöl
WO2008134712A2 (en) 2007-04-30 2008-11-06 Living Proof, Inc. Use of matrix metalloproteinase inhibitors in skin care
IL185775A (en) * 2007-09-06 2013-08-29 Mordechai Klein Pomegranate-derived products for the treatment of skin sores and lesions
US8263140B1 (en) 2008-04-16 2012-09-11 Pom Wonderful, Llc Pomegranate based skin protectant and topical application
US8911801B2 (en) 2008-10-06 2014-12-16 Woodcliff Skincare Solutions, Inc. Natural preservative alternatives and compositions containing same
EP2355793B1 (en) * 2008-11-12 2018-09-05 June Jacobs Laboratories, Llc Antioxidant compositions for the cleansing and conditioning of skin
GB0902040D0 (en) * 2009-02-06 2009-03-11 Seeds Lp Composition for treatment of skin
US8084409B2 (en) * 2009-04-21 2011-12-27 Bella Bella, Inc. Microdermabrasion soap bar compositions and methods of preparing same
AU2010302350B2 (en) * 2009-10-02 2015-06-18 Journey Medical Corporation Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
AU2010326134B2 (en) 2009-12-04 2013-06-13 Colgate-Palmolive Company Oral compositions containing a combination of natural extracts and related methods
WO2012090194A2 (en) * 2010-12-29 2012-07-05 Abrham Galya Compositions and methods for treating a skin disorder
MX2014001621A (es) 2011-08-11 2014-05-28 Stiefel Res Australia Pty Ltd Composiciones topicas antioxidantes.
US8545904B1 (en) * 2012-06-05 2013-10-01 Liquid Innovators, LLC Topical composition containing Carapa (andiroba) oil for psoriasis and other related dermatological disorders

Also Published As

Publication number Publication date
EP3212288A4 (en) 2018-06-20
EP4248981A3 (en) 2023-10-04
EP4248981A2 (en) 2023-09-27
US11058735B2 (en) 2021-07-13
EP3212288B1 (en) 2024-04-03
IL276734B2 (en) 2023-04-01
IL251772A0 (en) 2017-06-29
MX2023002137A (es) 2023-03-16
JP2021050249A (ja) 2021-04-01
JP7242718B2 (ja) 2023-03-20
EP4781996A2 (en) 2026-07-29
IL276734B (en) 2022-12-01
EP3212288A1 (en) 2017-09-06
WO2016070194A1 (en) 2016-05-06
IL276734A (en) 2020-09-30
CA2966325A1 (en) 2016-05-06
JP2017533960A (ja) 2017-11-16
IL251772B (en) 2020-09-30
JP7313118B2 (ja) 2023-07-24
US20170333504A1 (en) 2017-11-23
EP3212288C0 (en) 2024-04-03

Similar Documents

Publication Publication Date Title
MX2023002137A (es) Formulaciones que contienen aceite de semilla de granada, aceite del fruto de rosa canina y oleorresina o extracto de inula viscosa.
MX2022008663A (es) Composiciones alergenicas mixtas y metodos de uso de las mismas.
MX377649B (es) Composición que contiene una mezcla de extractos vegetales o una mezcla de moléculas contenidas en dichas plantas y uso para controlar el metabolismo de glúcidos y/o lípidos.
SG10201808104RA (en) Cenicriviroc for the treatment of fibrosis
MX2017006113A (es) Nuevos profarmacos polimericos de la hormona del crecimiento humana (hgh).
CO2018005971A2 (es) Composición de regulador de crecimiento vegetal que tiene efecto sinérgico
MX2016010328A (es) Tratamiento con halogeno de ataque cardiaco y lesion isquemica.
BR112017007748A2 (pt) “composição farmacêutica, agente antialérgico, composição alimentar, composição cosmética, uso de um extrato, e, método para prevenir ou tratar uma doença alérgica
MX379359B (es) Derivados de 8-amino-2-oxo-1,3-diaza-espiro-[4.5]-decano.
PL3199171T3 (pl) Kompozycja farmaceutyczna do leczenia i zapobiegania degeneracyjnym zaburzeniom neurologicznym, zawierająca, jako składnik aktywny, mieszaninę ekstraktu z kory korzenia piwonii drzewiastej, korzenia dzięgielu dahuryjskiego i korzenia przewiercienia lub ich frakcję
CL2018003827A1 (es) Nuevo extracto de aquenio silybum marianum y usos del mismo en la dermatología y dermocosméticos.
EA201592003A1 (ru) Микропищевые добавки для иммунитета
UY36405A (es) Formulaciones reguladoras/bioestimulantes del crecimiento de las plantas y de los cultivos y métodos para usarlas
MX2018000262A (es) Usos terapeuticos de formulaciones de berberina.
EP3539550C0 (en) Pharmaceutical composition for the prevention or treatment of neurodegenerative diseases, comprising as its active ingredient, lilac daphne flower extract.
FR3016289B1 (fr) Extrait vegetal comprenant des sucrose-esters en tant que principe actif et son utilisation dans une composition cosmetique, dermatologique ou nutraceutique
MY177827A (en) Combination of valerian root extract and lavender oil for use in the treatment of sleep disorders
CR20150478A (es) Método para el tratamiento y control de enfermedades de postrecolección de frutas y hortalizas y composiciones que comprenden extractos naturales y formulaciones fitofortificantes y/o fungicidas para aplicar en dicho método.
BR112018005847A2 (pt) composição de lipídeo de planta para estimular o crescimento de cabelo, método para estimular o crescimento de cabelo e uso dos referidos lipídeos de planta
MX2017016226A (es) Composiciones farmaceuticas que comprenden derivados de polialquilenglicol.
MX374832B (es) Formulacion cosmetica antioxidante para uso topico que comprende una asociacion de extractos de plantas y uso de la misma.
WO2015126151A3 (ko) 신곡 추출물을 포함하는 상처 치료용 조성물
BR112014032850A2 (pt) combinações de princípios ativos, preparações cosméticas ou dermatológicas, e, uso de combinações de princípios ativos
BR112017012931A2 (pt) métodos para redução de agregação plaquetária e tratamento de doença cardiovascular e outros distúrbios médicos
CR20140324A (es) Procedimiento para la administración de microorganismos antagonistas a patógenos en plantas del género musa sp. y especies relacionadas